Clinical Trial

Real-World Study of Crisugabalin(HSK16149) for the Treatment of Rosacea

Completed
View on ClinicalTrials.gov →
Summary
A Real-World Study of Crisugabalin(HSK16149) for the Treatment of Rosacea
Protocol Amendment History 4 changes
critical Trial status changed: Enrolling by Invitation → Completed 2026-07-22
notable Enrollment reduced: 60 -> 30 participants 2026-07-22
notable Primary completion moved earlier: 2026-10-30 -> 2026-04-30 2026-07-22
minor Completion moved earlier: 2026-12-30 -> 2026-04-30 2026-07-22
Trial Details
NCT Number NCT07606820
Lead Sponsor The First Affiliated Hospital with Nanjing Medical University
Conditions Rosacea
Enrollment 30 participants
Start Date 2025-10-29
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-21